Home	About us	Portfolio	Contact us	News
Portfolio		Portfolio

	Life Sciences	Neovasc is developing a minimally invasive treatment for Ischemic Heart Disease (IHD) patients who are not treatable by exisiting medical procedures.
	Life Sciences	NeuroSonix is developing non-invasive embolic protection devices for use in cardiac surgery and cath-lab practice.
	Life Sciences	B-Balloon is developing unique Stents and Stent Delivery Systems (SDS) that allow the safe percutaneous placement of Stents in Coronary Bifurcation and Ostial Lesions.
	Life Sciences	JoinTec is developing a intra-articular apparatus for intra-articular knee pressure reduction, as well as for evacuation of inflammatory mediators from painful-effused knees in both rheumatic & degenerative diseases affecting the knee joint.
	Life Sciences	Genetico is developing two-pronged RNA-switch technology that will allow the specific drug targeting of cancers and other viral diseased cells, while sparing all other healthy cells.
	Life Sciences	DiaLean develops better therapeutics for weight management and hormonal imbalance based on proprietary proteins DiaLean's founders havediscovered.
	Life Sciences	Apexum is developing a minimally invasive surgical tool that will offer an innovative core technology for intra-osseous surgery. The company focuses its initial efforts on dental applications for peri-apical lesions that are associated with root canal, allowing Endodonts to treat Periapical lesions in a minimally invasive fashion, supplementing a standard root canal treatment.
	Life Sciences	Valtech is developing Percutaneous Annuloplasty ring valve repair for the treatment of Mitral Valve Regurgitation.
	Life Sciences	NLT (NonLinear Technologies) is developing a family of orthopedic implant devices for the treatment of Spinal Stenosis and other spinal disorders using a minimally invasive procedure.
	Life Sciences	CardioNova develops a novel catheter to treat Atrial Fibrillation using cryoenergy.
	Life Sciences	Topsight Optics aims to develop unique telescopic glasses for use by visually impaired patients (ie/people who suffer from Age-Related Macular Degeneration). The company has implemented clinical experience with innovative design of lenses for the creation of a new type of telescopic system for low vision patients.
	Life Sciences	Otic Pharma develops foam-based solutions for the delivery of medications to treat ear disorders. The proprietary delivery system has clear advantages over the classical ear drops in terms of ease of use, efficacy and patient compliance.
	Telecommunications	Cellvine design, develop and market a wide range of cellular coverage and capacity solutions for the wireless telecom industry.
	Telecommunications	VIMPLICITY is developing a patented Instant Voice Messaging platform with Push and Presence capabilities.
	Telecommunications	Pallasium is developing technological solutions enabling WiMax and other OFDMA networks to increase their capacity by over three times their original capability.
	Software	Geomage develops and markets IT solutions for the global upstream petroleum industry. Geomage’s proprietary technology analyzes seismic data and offers accurate assessment of the subsurface structure, complete with reservoir visualization.
	Software	Eurekify develops and markets Eurekify Role Management ERM software, providing role management solutions for enterprise.
	Software	Rocketick develops an extremely cost-effective accelerator for chip-verification simulations. Its product will enable semiconductor companies to run simulations of huge SoCs 10x-100x faster, thereby significantly reducing their time-to-market and R&D costs.
	Energy	Developing the most cost -effective solar cells in the market. These solar cells will provide a first-time possibility for solar energy to be directly competitive with existing energy sources, without subsidies.
	Energy	FCV is developing critical components for the improvement of direct methanol fuel cells (DM-FC). The company is developing a new type of electrode that will provide functional and cost superiority.